vs
Side-by-side financial comparison of Albemarle Corporation (ALB) and Alignment Healthcare, Inc. (ALHC). Click either name above to swap in a different company.
Albemarle Corporation is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.2× Alignment Healthcare, Inc.). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs -29.0%, a 29.9% gap on every dollar of revenue. On growth, Albemarle Corporation posted the faster year-over-year revenue change (15.9% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 2.4%).
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
ALB vs ALHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.2B |
| Net Profit | $-414.2M | $11.4M |
| Gross Margin | 13.9% | — |
| Operating Margin | -15.2% | — |
| Net Margin | -29.0% | 0.9% |
| Revenue YoY | 15.9% | -74.7% |
| Net Profit YoY | -650.1% | — |
| EPS (diluted) | $-3.88 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.4B | $1.0B | ||
| Q3 25 | $1.3B | $993.7M | ||
| Q2 25 | $1.3B | $1.0B | ||
| Q1 25 | $1.1B | $926.9M | ||
| Q4 24 | $1.2B | $701.2M | ||
| Q3 24 | $1.4B | $692.4M | ||
| Q2 24 | $1.4B | $681.3M |
| Q1 26 | — | $11.4M | ||
| Q4 25 | $-414.2M | $-11.0M | ||
| Q3 25 | $-160.7M | $3.7M | ||
| Q2 25 | $22.9M | $15.7M | ||
| Q1 25 | $41.3M | $-9.1M | ||
| Q4 24 | $75.3M | $-31.1M | ||
| Q3 24 | $-1.1B | $-26.4M | ||
| Q2 24 | $-188.2M | $-24.0M |
| Q1 26 | — | — | ||
| Q4 25 | 13.9% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 14.5% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | -7.7% | — | ||
| Q2 24 | -0.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | -15.2% | -1.0% | ||
| Q3 25 | -16.6% | 0.8% | ||
| Q2 25 | 3.6% | 2.2% | ||
| Q1 25 | 1.8% | -0.6% | ||
| Q4 24 | 0.4% | -3.2% | ||
| Q3 24 | -81.9% | -2.8% | ||
| Q2 24 | -34.4% | -2.7% |
| Q1 26 | — | 0.9% | ||
| Q4 25 | -29.0% | -1.1% | ||
| Q3 25 | -12.3% | 0.4% | ||
| Q2 25 | 1.7% | 1.5% | ||
| Q1 25 | 3.8% | -1.0% | ||
| Q4 24 | 6.1% | -4.4% | ||
| Q3 24 | -78.9% | -3.8% | ||
| Q2 24 | -13.2% | -3.5% |
| Q1 26 | — | — | ||
| Q4 25 | $-3.88 | $-0.04 | ||
| Q3 25 | $-1.72 | $0.02 | ||
| Q2 25 | $-0.16 | $0.07 | ||
| Q1 25 | $0.00 | $-0.05 | ||
| Q4 24 | $0.29 | $-0.15 | ||
| Q3 24 | $-9.45 | $-0.14 | ||
| Q2 24 | $-1.96 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $705.6M |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $9.5B | $206.9M |
| Total Assets | $16.4B | $1.3B |
| Debt / EquityLower = less leverage | 0.33× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $705.6M | ||
| Q4 25 | — | $604.2M | ||
| Q3 25 | $1.9B | $644.1M | ||
| Q2 25 | $1.8B | $503.8M | ||
| Q1 25 | $1.5B | $479.5M | ||
| Q4 24 | $1.2B | $470.6M | ||
| Q3 24 | $1.7B | $381.0M | ||
| Q2 24 | $1.8B | $363.7M |
| Q1 26 | — | — | ||
| Q4 25 | $3.2B | $323.2M | ||
| Q3 25 | $3.6B | $322.7M | ||
| Q2 25 | $3.6B | $322.3M | ||
| Q1 25 | $3.5B | $321.9M | ||
| Q4 24 | $3.5B | $321.4M | ||
| Q3 24 | $3.6B | $212.0M | ||
| Q2 24 | $3.5B | $211.7M |
| Q1 26 | — | $206.9M | ||
| Q4 25 | $9.5B | $179.3M | ||
| Q3 25 | $10.0B | $161.9M | ||
| Q2 25 | $10.2B | $141.0M | ||
| Q1 25 | $10.0B | $108.1M | ||
| Q4 24 | $10.0B | $99.9M | ||
| Q3 24 | $10.2B | $114.5M | ||
| Q2 24 | $11.2B | $123.7M |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $16.4B | $1.1B | ||
| Q3 25 | $17.1B | $1.1B | ||
| Q2 25 | $17.3B | $1.0B | ||
| Q1 25 | $17.0B | $895.6M | ||
| Q4 24 | $16.6B | $782.1M | ||
| Q3 24 | $17.5B | $692.3M | ||
| Q2 24 | $18.4B | $716.3M |
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | 1.80× | ||
| Q3 25 | 0.36× | 1.99× | ||
| Q2 25 | 0.35× | 2.29× | ||
| Q1 25 | 0.35× | 2.98× | ||
| Q4 24 | 0.35× | 3.22× | ||
| Q3 24 | 0.35× | 1.85× | ||
| Q2 24 | 0.31× | 1.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $388.5M | $128.7M |
| Free Cash FlowOCF − Capex | $233.1M | — |
| FCF MarginFCF / Revenue | 16.3% | — |
| Capex IntensityCapex / Revenue | 10.9% | — |
| Cash ConversionOCF / Net Profit | — | 11.27× |
| TTM Free Cash FlowTrailing 4 quarters | $692.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $128.7M | ||
| Q4 25 | $388.5M | $-50.4M | ||
| Q3 25 | $355.6M | $144.6M | ||
| Q2 25 | $-7.2M | $29.1M | ||
| Q1 25 | $545.4M | $16.6M | ||
| Q4 24 | $674.0K | $-8.7M | ||
| Q3 24 | $240.5M | $26.2M | ||
| Q2 24 | $362.9M | $23.5M |
| Q1 26 | — | — | ||
| Q4 25 | $233.1M | $-55.4M | ||
| Q3 25 | $223.4M | $139.1M | ||
| Q2 25 | $-126.8M | $21.1M | ||
| Q1 25 | $362.8M | $8.4M | ||
| Q4 24 | $-355.1M | $-18.0M | ||
| Q3 24 | $-62.6M | $16.9M | ||
| Q2 24 | $-84.7M | $11.8M |
| Q1 26 | — | — | ||
| Q4 25 | 16.3% | -5.5% | ||
| Q3 25 | 17.1% | 14.0% | ||
| Q2 25 | -9.5% | 2.1% | ||
| Q1 25 | 33.7% | 0.9% | ||
| Q4 24 | -28.8% | -2.6% | ||
| Q3 24 | -4.6% | 2.4% | ||
| Q2 24 | -5.9% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 0.5% | ||
| Q3 25 | 10.1% | 0.6% | ||
| Q2 25 | 9.0% | 0.8% | ||
| Q1 25 | 17.0% | 0.9% | ||
| Q4 24 | 28.9% | 1.3% | ||
| Q3 24 | 22.4% | 1.3% | ||
| Q2 24 | 31.3% | 1.7% |
| Q1 26 | — | 11.27× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 38.77× | ||
| Q2 25 | -0.31× | 1.86× | ||
| Q1 25 | 13.19× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALB
| Energy Storage | $759.1M | 53% |
| Specialties | $348.9M | 24% |
| Ketjen | $320.1M | 22% |
ALHC
Segment breakdown not available.
